DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,152,629 | +22.4% | 963,976 | +18.4% | 0.11% | +25.3% |
| Q2 2023 | $195,342,464 | -20.7% | 813,927 | -16.7% | 0.09% | -26.3% |
| Q1 2023 | $246,206,327 | -12.4% | 976,854 | -7.7% | 0.12% | -18.6% |
| Q4 2022 | $280,907,612 | -0.9% | 1,058,351 | -3.6% | 0.14% | -10.5% |
| Q3 2022 | $283,522,000 | +2.2% | 1,097,687 | +0.3% | 0.16% | +4.5% |
| Q2 2022 | $277,429,000 | -13.3% | 1,094,308 | +0.3% | 0.16% | -3.7% |
| Q1 2022 | $320,164,000 | -10.1% | 1,091,481 | +0.9% | 0.16% | -8.5% |
| Q4 2021 | $355,948,000 | +13.2% | 1,081,877 | +4.7% | 0.18% | +1.7% |
| Q3 2021 | $314,520,000 | +14.1% | 1,033,110 | +0.6% | 0.17% | +10.9% |
| Q2 2021 | $275,579,000 | +20.7% | 1,026,901 | +1.2% | 0.16% | +5.4% |
| Q1 2021 | $228,407,000 | +25.9% | 1,014,782 | +24.3% | 0.15% | +8.0% |
| Q4 2020 | $181,377,000 | +5.5% | 816,498 | +2.3% | 0.14% | -9.9% |
| Q3 2020 | $171,882,000 | +29.3% | 798,226 | +6.2% | 0.15% | +16.9% |
| Q2 2020 | $132,933,000 | +42.2% | 751,755 | +11.3% | 0.13% | +17.1% |
| Q1 2020 | $93,494,000 | +16.0% | 675,483 | +28.7% | 0.11% | +30.6% |
| Q4 2019 | $80,579,000 | +17.9% | 525,010 | +10.9% | 0.08% | +13.3% |
| Q3 2019 | $68,363,000 | +9.8% | 473,332 | +8.7% | 0.08% | -3.8% |
| Q2 2019 | $62,249,000 | +25.0% | 435,551 | +15.4% | 0.08% | +14.7% |
| Q1 2019 | $49,813,000 | +28.9% | 377,314 | +0.6% | 0.07% | +13.3% |
| Q4 2018 | $38,658,000 | +4448.0% | 374,884 | +4690.8% | 0.06% | +5900.0% |
| Q3 2018 | $850,000 | -91.6% | 7,825 | -92.4% | 0.00% | -95.7% |
| Q2 2018 | $10,114,000 | +2.2% | 102,504 | +1.4% | 0.02% | -17.9% |
| Q1 2018 | $9,900,000 | -33.6% | 101,078 | -37.1% | 0.03% | -15.2% |
| Q4 2017 | $14,917,000 | +12.8% | 160,706 | +4.2% | 0.03% | +3.1% |
| Q3 2017 | $13,221,000 | +0.1% | 154,159 | -1.5% | 0.03% | -13.5% |
| Q2 2017 | $13,209,000 | -0.7% | 156,575 | +0.7% | 0.04% | -14.0% |
| Q1 2017 | $13,297,000 | +8.7% | 155,416 | -1.1% | 0.04% | -2.3% |
| Q4 2016 | $12,230,000 | +7.2% | 157,116 | +8.0% | 0.04% | 0.0% |
| Q3 2016 | $11,405,000 | +12.4% | 145,490 | +44.8% | 0.04% | +10.0% |
| Q2 2016 | $10,148,000 | +7.2% | 100,475 | +0.7% | 0.04% | -2.4% |
| Q1 2016 | $9,467,000 | -13.3% | 99,796 | -15.2% | 0.04% | -18.0% |
| Q4 2015 | $10,925,000 | +3.5% | 117,630 | -5.0% | 0.05% | -3.8% |
| Q3 2015 | $10,551,000 | -5.9% | 123,825 | -5.5% | 0.05% | -1.9% |
| Q2 2015 | $11,218,000 | +8.2% | 131,066 | +7.3% | 0.05% | -1.9% |
| Q1 2015 | $10,371,000 | +1048.5% | 122,150 | +1059.5% | 0.05% | +500.0% |
| Q4 2014 | $903,000 | -2.5% | 10,535 | -13.5% | 0.01% | 0.0% |
| Q3 2014 | $926,000 | -7.6% | 12,186 | -4.3% | 0.01% | -10.0% |
| Q2 2014 | $1,002,000 | +4.5% | 12,733 | -0.4% | 0.01% | -9.1% |
| Q1 2014 | $959,000 | -7.3% | 12,783 | -4.7% | 0.01% | -8.3% |
| Q4 2013 | $1,035,000 | +26.8% | 13,411 | +14.0% | 0.01% | +20.0% |
| Q3 2013 | $816,000 | +15.4% | 11,765 | +5.4% | 0.01% | +11.1% |
| Q2 2013 | $707,000 | – | 11,166 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |